Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

Abstract Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States. Few studies have investigated prescribing patterns among rheumatologists who have initiated secukinumab for the treatment of patie...

Full description

Bibliographic Details
Main Authors: Prashanth Sunkureddi, Dominick Latremouille-Viau, Mark K. Meiselbach, Jipan Xie, Peter Hur, Reeti Joshi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-01-01
Series:Rheumatology and Therapy
Subjects:
Biologicals
Epidemiology
Psoriatic arthritis
Spondylarthropathies
Online Access:http://link.springer.com/article/10.1007/s40744-018-0137-z

Internet

http://link.springer.com/article/10.1007/s40744-018-0137-z

Similar Items